Dr. Ryan H. Dougherty, MD

Dr. Dougherty practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Dougherty's NPI, 1942317409, was assigned on August 23, 2006. Dr. Dougherty graduated from The Johns Hopkins University School of Medicine in 2002. Dr. Dougherty holds California license A90594.

Dr. Dougherty's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Dougherty's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Dougherty is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Dougherty to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dougherty practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Dougherty's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Dougherty is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dougherty's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists asthma, atrial fibrillation and flutter, chronic lung disease, chronic obstructive pulmonary disease (COPD), cirrhosis of the liver, heart failure, intermittent racing heartbeat (PSVT) and pleural effusion among the conditions Dr. Dougherty treats.

CMS data shows 663 Medicare services from Dr. Dougherty across 9 procedure codes in 2024, for 389 Medicare patients. Medicare paid $105,090 for them.

CMS counts 389 Medicare patients who saw Dr. Dougherty in 2024. The largest group is 75 to 84, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dougherty's median patient age at 72, with 51% women.

In 2024, Dr. Dougherty wrote 862 Medicare Part D claims for 159 patients. 40% of them were for generic drugs. CMS names the drug for 678 of them, across 23 drugs with 11 or more claims each, at $1,140,749 in total drug cost. In 2023, CMS named 558 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Dougherty for performance year 2024, reported as part of a group. Dr. Dougherty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dougherty as offering telehealth.

Dmand AI links 11 papers to Dr. Dougherty, published from 2009 to 2023. 2010 was the busiest year, with 2. The most frequent topics are Asthma, Apoptosis and Cell Division. Dr. Dougherty has published most often in Am J Respir Crit Care Med. Dr. Dougherty's most frequent co-authors are Anh Lan Innes, MD, Prescott G. Woodruff, MD and George Herbert Caughey, MD.

Dmand AI links Dr. Dougherty to 1 clinical trial. Conditions studied include Bronchitis and Cystic Fibrosis.

CMS Open Payments shows 193 general payments to Dr. Dougherty from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $895.

Dr. Dougherty graduated from The Johns Hopkins University School of Medicine in 2002.

Dr. Dougherty is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.